Canary Capital Amends Staked Injective ETF Filing With SEC
Injective (INJ)
Editor:
Eugene Serbin
bitcoinethereumnews.com reports that Canary Capital amended its staked Injective ETF filing with the U.S. Securities and Exchange Commission. The issuer revealed significant changes to its prospectus to provide investors with regulated exposure to Injective and staking rewards. The outlet notes that the INJ price rebounded following the update.
How the market reacted
Whalio's own Binance spot order flow for INJ, measured when this story was written up on 25 September 2026. Not the outlet's figures.
Whalio data shows the INJ spot price at $8.05 with a 1-hour buy ratio of 56.1%, which is higher than the 24-hour ratio of 50.5%, indicating that buying pressure is building in the short term. The 4-hour buy ratio sits at 52.1%, also above the daily average, suggesting sustained interest. Volume delta is positive at +$80,725 for the hour and +$201,936 for the 4-hour window, meaning buyers are actively absorbing sell orders. This positive flow contrasts with the 24-hour cumulative volume delta of -$332,087, showing that recent aggressive buying is offsetting earlier selling pressure.
The latest daily buy ratio of 53.4% sits at the 91st percentile of the last 322 days, against a median of 49.8% - among the strongest buying days it has had.
Was that an ordinary day?
The same Binance spot measurements for INJ, averaged over the days leading up to the story.
Over the preceding week, the average buy ratio was 49.9%, making the current 24-hour ratio of 50.5% slightly elevated by 0.6 points. Spot volume for the day is 1.04x the weekly average, indicating a marginally busier trading environment. Net buying occurred on 3 of the past 7 days, with a total volume delta of +$330,549 over that period. This recent activity follows an 8-day price change of +40.6%, highlighting a period of significant upward momentum.